Partner with Hikma.
We offer high-quality manufacturing capabilities, combining reliability and flexibility in our state-of-the-art facilities. With 30 manufacturing plants strategically located across the US, Europe, and the MENA region, we ensure that your needs are met with excellence.
Oral and nasal expertise
Dosage Forms
Tablets/Capsules
Nasals
Oral Solutions
High Containment
Respiratory
Controlled Substances
Packaging
Bottle
Blister
Bulk
Cold Storage
Custom
Distribution
FDA
EMA-Licensed Facilities
Support 100+ Countries
10,000+ Pallets of International Exports Annually
Proven Performance
Robust and Rapid-tech Transfer Process
Excellent On-Time Track Record
Technology and Process Improvement Solutions
Excellent Safety Record
Best-in-Class TRIR Safety Performance
ZERO critical FDA observations for over a decade
Exceptional Compliance Track Record
Lean on us. Call today
Or call
We have solutions for every stage in the pharmaceutical development cycle
Latest news
- Sell-side analysts and investors visit Hikma Casablanca site Press Release, Corporate 14 November 2024 Sell-side analysts and investors visit Hikma Casablanca site
- Hikma continues strong strategic execution and reiterates guidance Press Release, Financial Results 07 November 2024 Hikma continues strong strategic execution and reiterates guidance
- Hikma launches Foscarnet Sodium Injection, in the US Press Release, Product 23 September 2024 Hikma launches Foscarnet Sodium Injection, in the US
- Hikma completes Xellia acquisition Press Release, Corporate 10 September 2024 Hikma completes Xellia acquisition